4//SEC Filing
Crockett Thomas Andrew 4
Accession 0001415889-24-004120
CIK 0001348911other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:20 PM ET
Size
5.4 KB
Accession
0001415889-24-004120
Insider Transaction Report
Form 4
Crockett Thomas Andrew
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-02-14$15.01/sh−58,356$875,883→ 181,676 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance stock units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001690920
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:20 PM ET
- Size
- 5.4 KB